Kathryn Swoboda

Credentials: · · ·

History

Neural and Non-Neural Contributions to Phenotype in Human SMA Type 1
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $463.4K · Massachusetts General Hospital
2018–2020
The Utah Regional Network for Excellence in Neuroscience Clinical Trials
National Institute of Neurological Disorders and Stroke · U10
PI · $895.8K · Utah State Higher Education System--University of Utah
2011–2018
Newborn Screening for Identification & Prospective Followup of Infants with SMA
National Institute of Child Health and Human Development · R01
Contact PI · $4.3M · Massachusetts General Hospital
2011–2018
Therapeutic Opportunities in Spinal Muscular Atrophy
National Institute of Child Health and Human Development · R01
Contact PI · $1.5M · Utah State Higher Education System--University of Utah
2007–2013

Prospective Evaluation of Infants With Spinal Muscular Atrophy:
Principal investigator · Unknown
Massachusetts General Hospital
2016
Study of Kuvan Treatment in Adults With GTPCH Deficiency
Principal investigator · Completed · Phase 1, Phase 2
University of Utah
2011–2013
Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
Principal investigator · Completed · Phase 1, Phase 2
University of Utah
2009–2011
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
Principal investigator · Completed · Phase 1, Phase 2
University of Utah
2008–2012